Biotech | April 06, 2026
Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial
Safety was equally impressive. ENV-294 was well tolerated
Safety was equally impressive. ENV-294 was well tolerated
The company spotlights micronutrient’s role in immunity, skin and bone health through digital and radio outreach on National Vitamin C Day
The therapy works by targeting interleukin-13, a key driver of inflammation behind eczema symptoms such as itching, skin damage, and infection
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
India’s largest glycolic acid manufacturer will unveil AviGa Bio HP70 on April 14, 2026
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The company announced positive topline data from the Phase 3 ADorable-1 trial
One task, one interaction, one pair, experts advocate
The conflict is also triggering a widening public health emergency
Subscribe To Our Newsletter & Stay Updated
